Community oncology practices may see up to a 25% earnings decline in 2023 due in part to the sunset of the Oncology Care Model (OCM), a value-based care program created by CMS and now succeeded by the Enhancing Oncology Model (EOM). There are several key challenges associated with this earnings shift including regulatory changes to drug revenue, increasing costs, and higher standards for outcome-based care. And to add to the complexity, EOM doesn’t start until July 2023, meaning many practices were left with a one-year gap to shoulder patient-care investments and operations with limited or no reimbursement.
Canopy, the first Intelligent Care Platform for oncology, today announced results from a seventeen-month, real-world study of their ePRO-based patient monitoring platform. The single-site study of 923 patients at Highlands Oncology Group demonstrates the Canopy platform can be effectively implemented at a large scale with a high level of long-term patient enrollment, engagement, and retention. The study also found that the vast majority of patient issues were effectively resolved by nurse specialists and physician intervention was infrequently required.
Are you currently evaluating the Enhancing Oncology Model (EOM) or other value-aligned payment programs? Canopy hosted a virtual panel discussion on strategies for the EOM and outcome-based care delivery, featuring thought leaders in community oncology:
Canopy, the first Intelligent Care Platform for oncology, today announced they will be presenting their research on the patient impact of their ePRO-based patient monitoring platform at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7.
Canopy, the Intelligent Care Platform (ICP) for oncology, today announced it has raised$13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest, and other industry leaders and executives, such as Geoff Calkins (former SVP Product, Flatiron Health), and Chris Mansi (CEO Of Viz.AI). Formerly known as Expain, Canopy is also launching out of stealth today to make its platform generally available to cancer treatment centers across the U.S.
